Tang X, Valdez BC, Ma Y, Zhang Q, et al. Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2021 Feb 26. pii: 10.1038/s41409-021-01238.
PMID: 33637882